Actin as A Marker in Cancer Management and Prevention

Rao, Jianyu

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29CA071081-05
• Application #: 2895563
• Study Section: Metabolic Pathology Study Section (MEP)
• Program Officer: Liu, Yung-Pin
• Project Start: 1995-09-10
• Project End: 2001-08-31
• Budget Start: 1999-09-01
• Budget End: 2001-08-31
• Support Year: 5
• Fiscal Year: 1999

Institution

• Name: University of California Los Angeles
• Department: Pathology
• Type: Schools of Medicine
• DUNS #: 119132785
• City: Los Angeles
• State: CA
• Country: United States
• Zip Code: 90095

Publications

Cheng, Lirong; Reiter, Robert E; Jin, Yusheng et al. (2003) Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens. J Urol 169:2094-100

Rao, JianYu; Seligson, David; Visapaa, Harri et al. (2002) Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer 95:1247-57

Rao, J Y; Jin, Y S; Zheng, Q et al. (1999) Alterations of the actin polymerization status as an apoptotic morphological effector in HL-60 cells. J Cell Biochem 75:686-97